Abstract:Background: The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be re-optimized due to differences in fabrication techniques for clinical production. Several low flow microfluidic synthesis processes have been reported in recent years for developing nanoparticles that are a hybrid between polymeric nanoparticles and liposomes. However, use of high flow microfluidic synthetic techniques has not been described for this type of nanoparticle system, which we will term as nanolipomer. In this manuscript, we describe the successful optimization and functional assessment of nanolipomers fabricated using a microfluidic synthesis method under high flow parameters. Results: The optimal total flow rate for synthesis of these nanolipomers was found to be 12 ml/min and flow rate ratio 1:1 (organic phase: aqueous phase). The PLGA polymer concentration of 10 mg/ml and a DSPE-PEG lipid concentration of 10% w/v provided optimal size, PDI and stability. Drug loading and encapsulation of a representative hydrophobic small molecule drug, curcumin, was optimized and found that high encapsulation efficiency of 58.8% and drug loading of 4.4% was achieved at 7.5% w/w initial concentration of curcumin/PLGA polymer. The final size and polydispersity index of the optimized nanolipomer was 102.11 nm and 0.126, respectively. Functional assessment of uptake of the nanolipomers in C4-2B prostate cancer cells showed uptake at 1 h and increased uptake at 24 h. The nanolipomer was more effective in the cell viability assay compared to free drug. Finally, assessment of in vivo retention in mice of these nanolipomers revealed retention for up to 2 h and were completely cleared at 24 h. Conclusions: In this study, we have demonstrated that a nanolipomer formulation can be successfully synthesized and easily scaled up through a high flow microfluidic system with optimal characteristics. The process of developing nanolipomers using this methodology is significant as the same optimized parameters used for small batches could be translated into manufacturing large scale batches for clinical trials through parallel flow systems.

Transitioning the production of lipidic mesophase-based delivery systems from lab-scale to robust industrial manufacturing following a risk-based quality by design approach augmented by artificial intelligence

Scalable microfluidic method for tunable liposomal production by a design of experiment approach

Leveraging machine learning to streamline the development of liposomal drug delivery systems

Design and development of topical liposomal formulations in a regulatory perspective

Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres

Microfluidic nanoparticle synthesis for oral solid dosage forms: a step toward clinical transition processes

Liposome production by microfluidics: potential and limiting factors

Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform

Production of liposomes by microfluidics: The impact of post-manufacturing dilution on drug encapsulation and lipid loss

Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies

Experimental and Numerical Integrated Strategy for the Optimization of Microfluidic Parameters for Eudragit L100 Nanoparticles and Microparticles

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials

A Proposed Methodology for a Risk Assessment-Based Liposome Development Process

Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation

Microemulsion systems: from the design and architecture to the building of a new delivery system for multiple-route drug delivery

Unlocking new dimensions in long-acting injectables using lipid mesophase-based beads

Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations

Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications

Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids

Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs

Improving Product Quality with Entrapped Stable Emulsions: From Theory to Industrial Application